Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful treatment with atomoxetine of an adolescent boy with attention deficit/hyperactivity disorder, extreme obesity, and reduced melanocortin 4 receptor function.

Obesity facts - 1 Jan 2013

Pott Wilfried, Albayrak Ozgür, Hinney Anke, Hebebrand Johannes, Pauli-Pott Ursula

Abstract excerpt

OBJECTIVE: Recent case reports suggest a link between reduced melanocortinergic tone and both obesity and attention deficit / hyperactivity disorder (ADHD). We present the case of a 13-year-old, male, obese MC4R mutation carrier with ADHD. CASE REPORT: The boy carries a heterozygous mutation in the melanocortin 4 receptor gene (MC4R; Met281Val), that leads to a reduced receptor function. Dominant mutations of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Obesity

Share to Receptor, Melanocortin, Type 4

Share to Risk Reduction Behavior

Share to Treatment Outcome

Share to Weight Loss

Source

Open in PubMed Open full text

Identifiers

PMID: 23493066
DOI: 10.1159/000348792
PMCID: PMC5644743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Successful treatment with atomoxetine of an adolescent boy with attention deficit/hyperactivity disorder, extreme obesity, and reduced melanocortin 4 receptor function.PMID 23493066Read ↗

Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder.Semantic proximity Read ↗

Role of ADHD symptoms as a contributing factor to obesity in patients with MC4R mutations.Semantic proximity Read ↗

Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: a newly described expression of MC4R deficiency.Semantic proximity Read ↗

Treatment options for children with monogenic forms of obesity.Semantic proximity Read ↗

Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene.Semantic proximity Read ↗

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.Semantic proximity Read ↗

Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI-SDS-A case series.Semantic proximity Read ↗

Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks.Semantic proximity Read ↗

Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.